Trial Profile
Efficacy and mortality of Tenofovir, entecariv and lamivudine treatment in patients with severe acute exacerbation of chronic hepatitis B
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Jul 2017
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Lamivudine (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Adverse reactions
- 07 Jul 2017 New trial record